This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henke, C. Articles by Polunovsky, V. Search for Related Content PubMed PubMed Citation Articles by Henke, C. Articles by Polunovsky, V.

American Journal of Pathology, Vol 149, 1639-1650, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease

C Henke, P Bitterman, U Roongta, D Ingbar and V Polunovsky
Department of Medicine, University of Minnesota, Minneapolis 55455, USA.

Fibroblast migration and proliferation within the alveolar wall and airspace after lung injury can lead to the development of fibrosis. Fibroblast cell surface CD44 is an adhesion receptor for provisional matrix proteins and mediates fibroblast invasion into fibrin matrices. Here we show that incubation of cultured fibroblasts with an anti-CD44 monoclonal antibody induces fibroblast detachment from the substratum and morphological changes compatible with apoptosis. In addition, we show that anti-CD44 monoclonal antibody rapidly induces fibroblast apoptosis within fibrin matrices. The effect of anti-CD44 antibody on induction of fibroblast apoptosis occurred within 8 hours and was dose dependent. Anti-CD44 antibody also induced fibroblast apoptosis in suspension. Furthermore, fibroblasts plated on anti-CD44-antibody- coated surfaces initially attached and spread on the antibody; however, after an 8-hour incubation time, many of the cells developed characteristic morphological features of apoptosis. Collectively, these data indicate that apoptosis did not result solely due to detachment from the substratum. Our results identify a new function for fibroblast cell surface CD44 related to the control of cell viability. We suggest this function may be important in fibroblast population control and could potentially be exploited in designing anti-fibrotic therapies.

This article has been cited by other articles:

				P. Huebener, T. Abou-Khamis, P. Zymek, M. Bujak, X. Ying, K. Chatila, S. Haudek, G. Thakker, and N. G. Frangogiannis CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response J. Immunol., February 15, 2008; 180(4): 2625 - 2633. [Abstract] [Full Text] [PDF]

				V. J. Thannickal and J. C. Horowitz Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proceedings of the ATS, January 1, 2006; 3(4): 350 - 356. [Abstract] [Full Text] [PDF]

				R. S. Hauptschein, K. E. Sloan, C. Torella, R. Moezzifard, M. Giel-Moloney, C. Zehetmeier, C. Unger, L. L. Ilag, and D. G. Jay Functional Proteomic Screen Identifies a Modulating Role for CD44 in Death Receptor-Mediated Apoptosis Cancer Res., March 1, 2005; 65(5): 1887 - 1896. [Abstract] [Full Text] [PDF]

				J. Choi, A. M. Miller, M. J. Nolan, B. Y. J. T. Yue, S. T. Thotz, A. F. Clark, N. Agarwal, and P. A. Knepper Soluble CD44 Is Cytotoxic to Trabecular Meshwork and Retinal Ganglion Cells In Vitro Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 214 - 222. [Abstract] [Full Text] [PDF]

				R. J. McKallip, Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens Int. Immunol., September 1, 2002; 14(9): 1015 - 1026. [Abstract] [Full Text] [PDF]

				B. Tian, K. Lessan, J. Kahm, J. Kleidon, and C. Henke beta 1 Integrin Regulates Fibroblast Viability during Collagen Matrix Contraction through a Phosphatidylinositol 3-Kinase/Akt/Protein Kinase B Signaling Pathway J. Biol. Chem., June 28, 2002; 277(27): 24667 - 24675. [Abstract] [Full Text] [PDF]

				P. A. Knepper, C. S. K. Mayanil, W. Goossens, R. D. Wertz, C. Holgren, R. Ritch, and R. R. Allingham Aqueous Humor in Primary Open-Angle Glaucoma Contains an Increased Level of CD44S Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 133 - 139. [Abstract] [Full Text] [PDF]

				H. L. HADDEN and C. A. HENKE Induction of Lung Fibroblast Apoptosis by Soluble Fibronectin Peptides Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1553 - 1560. [Abstract] [Full Text] [PDF]

				M. E. Mummert, M. Mohamadzadeh, D. I. Mummert, N. Mizumoto, and A. Takashima Development of a Peptide Inhibitor of Hyaluronan-mediated Leukocyte Trafficking J. Exp. Med., September 11, 2000; 192(6): 769 - 780. [Abstract] [Full Text] [PDF]

				B. M. Wittig, B. Johansson, M. Zoller, C. Schwarzler, and U. Gunthert Abrogation of Experimental Colitis Correlates with Increased Apoptosis in Mice Deficient for CD44 Variant Exon 7 (CD44v7) J. Exp. Med., June 12, 2000; 191(12): 2053 - 2064. [Abstract] [Full Text] [PDF]

				S. Bruno, M. Fabbi, M. Tiso, B. Santamaria, F. Ghiotto, D. Saverino, C. Tenca, D. Zarcone, S. Ferrini, E. Ciccone, et al. Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis Carcinogenesis, May 1, 2000; 21(5): 893 - 900. [Abstract] [Full Text] [PDF]

				H. Warschkau and A. F. Kiderlen A Monoclonal Antibody Directed Against the Murine Macrophage Surface Molecule F4/80 Modulates Natural Immune Response to Listeria monocytogenes J. Immunol., September 15, 1999; 163(6): 3409 - 3416. [Abstract] [Full Text] [PDF]

				G. Filippatos, C. Leche, R. Sunga, A. Tsoukas, P. Anthopoulos, I. Joshi, A. Bifero, R. Pick, and B. D. Uhal Expression of FAS adjacent to fibrotic foci in the failing human heart is not associated with increased apoptosis Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H445 - H451. [Abstract] [Full Text] [PDF]

				N. Ohta, H. Saito, T. Kuzumaki, T. Takahashi, M.M. Ito, T. Saito, K. Nakahara, and M. Hiroi Expression of CD44 in human cumulus and mural granulosa cells of individual patients in in-vitro fertilization programmes Mol. Hum. Reprod., January 1, 1999; 5(1): 22 - 28. [Abstract] [Full Text] [PDF]

				A. TAN, H. LEVREY, C. DAHM, V. A. POLUNOVSKY, J. RUBINS, and P. B. BITTERMAN Lovastatin Induces Fibroblast Apoptosis In Vitro and In Vivo . A Possible Therapy for Fibroproliferative Disorders Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 220 - 227. [Abstract] [Full Text]

				J. B. RUBINS, T. GREATENS, R. A. KRATZKE, A. T. TAN, V. A. POLUNOVSKY, and P. BITTERMAN Lovastatin Induces Apoptosis in Malignant Mesothelioma Cells Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1616 - 1622. [Abstract] [Full Text]